Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review

Published:2022-07-22 Issue:5 Volume:29 Page:e520-e533
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Davoudi-Monfared Effat,Ahmadi Arezoo,Karimpour-Razkenari Elahe,Shahrami Bita,Najmeddin Farhad,Mojtahedzadeh Mojtaba

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference66 articles.

1. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China;Zhang;Allergy,2020

2. A promising antiviral candidate drug for the COVID-19 pandemic: a mini-review of remdesivir;Liang;Eur J Med Chem.,2020

3. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018

4. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase;Brown;Antivir Res,2019

5. Remdesivir for the treatment of covid-19—final report;Beigel;N Engl J Med.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center;Annals of Medicine;2024-06-03

2. Supersaturated Drug Delivery System of Oxyberberine Based on Cyclodextrin Nanoaggregates: Preparation, Characterization, and in vivo Application;International Journal of Nanomedicine;2024-06

3. Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?;Nefrología (English Edition);2024-05

4. Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment;BMC Infectious Diseases;2024-01-02

5. Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency;Journal of Infection and Chemotherapy;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3